Hi-Tech Pharmacal Co.‘s (HITK) share price has entered into oversold territory with a stochastic value of 16.140. The Zacks Consensus Estimate on the company’s earnings for April 2012 increased by 29 cents over the past week to $3.61 per share. Hi-Tech Pharmacal Co. is a Zacks #1 Rank (“Strong Buy”) company.

Zacks Investment Research